Questions and Answers: Study on New Genomic Techniques

Questions and Answers: Study on New Genomic Techniques

What are New Genomic Techniques (NGTs)?

How can NGTs change the genome?

What is the difference between organisms produced by conventional breeding, established genetic modification techniques (GMOs approved so far under the current legislation), and by NGTs?

How are these products regulated in the EU?

Are there products obtained by NGTs already marketed in the agri-food sector?

Why did the Commission prepare a study on NGTs?

What is the scope and objective of the study?

How did the Commission prepare this study?

What has the European Food Safety Authority concluded on safety?

What does the study conclude on the legal status of organisms produced by NGTs?

Did the study identify potential benefits of NGTs, in particular in the context of the Farm to Fork Strategy?

Did the study identify potential benefits of NGTs beyond the agri-food sector?

Were any potential concerns on NGTs raised during the consultation process of the study?

Did the study identify any challenges in the application of the GMO legislation to NGTs?

What is the study’s main conclusion?

Will there be any follow-up policy action?

What are the next steps?

Why take action only for plants from specific NGTs? What about the rest?